What happened
System raised $20M to run the full chain: patient, US-licensed clinician, certified compounding pharmacy, front door. Glutathione, NAD+, sermorelin and MIC+B12 on the menu, all 50 states, with API manufacturing on the roadmap.
What it means for practice
peptides are becoming what supplements were ten years ago, and venture money is building the layer between the gray market and your exam room. Members will keep being asked for mail-order stacks. Set your formulary, your 503A/503B sourcing standard and your consent language before a platform sets them for you. A raise is not evidence. No peptide on that list is a longevity drug.
Originally published in The Longevity Medicine Intelligence newsletter (#106).
WRITTEN BYlongevitydocs™ editorsCurated by the longevitydocs™ editorial team from the weekly newsletter
